Physician profile
Mikhail Kazachkov
NPI 1417942590
$6,949.96
in general payments reported to CMS, 2019-2025
10 companies · $17.56 in 2025
The $17.56 reported for 2025 was less than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,968 · 2020: $69.53 · 2021: $432 · 2022: $3,133 · 2023: $166 · 2024: $164 · 2025: $17.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $3,035.47 | 2022 | |
| Ptc Therapeutics, INC. | $2,950.15 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $364.70 | 2022-2025 | Dupixent |
| Hill-Rom Services, INC | $360.00 | 2021 | |
| Advanced Respiratory, INC | $95.81 | 2020-2021 | |
| Genzyme Corporation | $59.18 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.00 | 2020 | |
| Philips North America LLC | $21.79 | 2024 | (Ak6) Vest Therapy |
| Ventec Life Systems, INC. | $21.30 | 2020 | |
| Novartis Pharmaceuticals Corporation | $17.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mikhail Kazachkov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.